Newsletter

Benefits and Risks of Participation in Clinical Trials of Experimental Cancer Drugs: A Meta-Analysis Study

Research findings have shown that participation in clinical trials of experimental cancer drugs slightly increases progression-free survival (PFS), but increases toxicity-related side effects. The results of a study on the benefits and risks of a randomized clinical trial of experimental cancer drugs conducted by researchers including Renata Iskander of McGill University in Montreal, Quebec, Canada, […]

Multiplex PCR Panel Detects Antibiotic Resistance Genes in Blood Cultures in One Hour: Positive Results in Clinical Trials

The multiplex polymerase chain reaction (PCR) panel, which detects antibiotic resistance genes and blood culture-positive disease-causing pathogens within one hour, has achieved positive scores in real-world clinical trials. It was recognized for its speed and accuracy by detecting 43 target genes with an accuracy of 98.1% within 1 hour. Experts therefore explain that this could […]

The Future of Dyslipidemia Treatment: RNA and Antibody-Based Therapies Changing the Game

PCSK9, ACL/AMPK, PPARα, ApoC-III, ANGPTL3, Apo(a), siRNA,. The dyslipidemia treatment market is changing rapidly. Recently, it has even accelerated. With the development of new drugs for dyslipidemia that rely not only on traditional chemicals but also on RNA and antibodies, the question of how much it is possible to lower lipid levels has now extended […]

Revolutionizing Dyslipidemia Treatment: The Future of Lipid-Lowering Drugs and Therapies

PCSK9, ACL/AMPK, PPARα, ApoC-III, ANGPTL3, Apo(a), siRNA,. The dyslipidemia treatment market is changing rapidly. Recently, it has even accelerated. With the development of new drugs for dyslipidemia that rely not only on traditional chemicals but also on RNA and antibodies, the question of how much it is possible to lower lipid levels has now extended […]

Long-term Study Shows Erenumab’s Continued Efficacy in Preventing Migraines

Research results have shown that the preventive migraine drug erenumab shows long-term therapeutic effects even in patients who have failed preventive treatment. The results of a study on the administration of erenumab in patients with episodic migraine who did not respond to preventive treatment, conducted by researchers including Uwer Reuter, Department of Neurology, Charité University […]

Long-Term Study Shows Erenumab Effective in Migraine Patients Resistant to Preventive Treatment

Research results have shown that the preventive migraine drug erenumab shows long-term therapeutic effects even in patients who have failed preventive treatment. The results of a study on the administration of erenumab in patients with episodic migraine who did not respond to preventive treatment, conducted by researchers including Uwer Reuter, Department of Neurology, Charité University […]

New Studies Support Effectiveness of Omega-3 in Lowering Mortality Rates

Omega-3, which has been plagued by controversy with results varying from study to study, has now received the backing of studies that support its effectiveness. This time, the results showed that the higher the body concentration of DHA, one of the components of omega-3, the lower the mortality rate. The results of a study on […]